Baihui Ou – Trademark Portfolio
Entity Type: 01
Baihui Ou holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 7 filings in this category. The portfolio also extends into Class 25 (Clothing) across 6 Nice Classification classes. Currently, 11 trademarks are registered and 2 are pending. Notable registered marks include LASEA, LAFACE, LAGLOW, VERYJEN, and LAMIRROR. The owner is based in Shenzhen.
Jia An Road Bao'an District
503 Building 3 Xi Long Wan Apartment #3
Shenzhen 518101 , CN
Showing of trademarks Trademarks
Trademark Classifications
Baihui Ou's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Baihui Ou have?
Baihui Ou has 14 U.S. trademarks filed with the USPTO. Of these, 11 registered, 2 pending, 1 abandoned.
What trademark classes does Baihui Ou file in?
Baihui Ou files trademarks across 6 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 25 (Clothing), Class 41 (Education & Entertainment), Class 43 (Hotels & Restaurants), Class 3 (Cosmetics & Cleaning). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Baihui Ou's most well-known trademarks?
Baihui Ou's registered trademark portfolio includes well-known marks such as LASEA, LAFACE, LAGLOW, VERYJEN, and LAMIRROR. These are among 11 currently registered trademarks in the portfolio.
What is Baihui Ou's trademark registration success rate?
Baihui Ou has a 92% trademark registration rate, with 11 out of 12 resolved applications resulting in successful registration. Currently, 2 applications are pending review.